/ WST
West Pharmaceutical (WST) Sets 2024 EPS Guidance at $7.50-$7.75
WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.
February 15, 2024WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.
February 15, 2024